
The information on this page about Lazid Tablet – Lamivudine 150mg + Zidovudine 300mg is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Lazid Tablet is a prescription-only antiretroviral medicine used as part of doctor-prescribed HIV treatment (ART) for HIV-1 infection and must be taken only under the supervision of a qualified healthcare professional. Do not self-medicate, change the dose, skip doses, or stop treatment without medical advice.
Always inform your doctor about your medical history, blood counts, liver or kidney conditions, Hepatitis B status, allergies, and any medicines or supplements you take. Because Lazid Tablet contains Zidovudine, periodic complete blood count (CBC) monitoring is recommended during treatment. Lazid Tablet does not cure HIV/AIDS and should be used with regular medical follow-ups and monitoring as advised by your doctor.
Medically reviewed by qualified clinicians at TAAL+ Healthcare. Last reviewed: July 2026.

This page has been medically reviewed by TAAL+ Healthcare Specialist Doctors, including professionals experienced in HIV medicine, infectious diseases, sexual wellness, preventive care, and long-term patient management.
Our clinical review process helps ensure that the medical information on this page is reviewed for accuracy, patient relevance, and alignment with current HIV treatment and ART care practices.
Clinical Areas: HIV Treatment (ART), PrEP, PEP, STI & STD Care, Sexual Wellness, Mental Health Support
Last Updated: July 2026
Lazid Tablet is a Schedule H prescription-only antiretroviral medicine containing Lamivudine 150mg + Zidovudine 300mg, used as part of combination antiretroviral therapy (ART) for HIV-1 infection. Because this medicine requires periodic blood count (CBC) monitoring and regular treatment follow-up, it should only be taken under medical supervision and exactly as prescribed by your doctor.